Cefotetan versus piperacillin in the prophylaxis of abdominal and vaginal hysterectomy: a prospective randomized study

Drugs Exp Clin Res. 1989;15(6-7):315-20.

Abstract

A prospective randomized study was carried out on a total of 686 patients who underwent vaginal or abdominal hysterectomy. Of these, 338 were given prophylactic cefotetan (2 g) and 348 piperacillin (2 g). Both drugs were administered as i.v. bolus 30 min before operation. Findings confirm the higher risk of infection with abdominal hysterectomy and the advantages of the long half-life cephalosporin, cefotetan.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Cefotetan / therapeutic use*
  • Female
  • Humans
  • Hysterectomy*
  • Hysterectomy, Vaginal*
  • Piperacillin / therapeutic use*
  • Premedication*
  • Randomized Controlled Trials as Topic
  • Surgical Wound Infection / microbiology
  • Surgical Wound Infection / prevention & control*

Substances

  • Cefotetan
  • Piperacillin